Maravai Lifesciences Holdings (MRVI) Invested Capital (2020 - 2026)

Maravai Lifesciences Holdings' Invested Capital history runs 7 years deep, the most recent figure standing at $610.1 million for Q1 2026.

• In Q1 2026, Invested Capital fell 26.07% year-over-year to $610.1 million; the TTM figure through Mar 2026 stood at $610.1 million (down 26.07% YoY), while the FY2025 annual figure was $504.2 million, down 42.26% from the prior year.
• Invested Capital was $610.1 million for Q1 2026 at Maravai Lifesciences Holdings, up from $504.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.4 billion in Q4 2022 to a low of $504.2 million in Q4 2025.
• Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Invested Capital jumped 58.44% in 2022, then slumped 42.26% in 2025.
• A 5-year view of Invested Capital shows it stood at $1.4 billion in 2022, then decreased by 8.28% to $1.3 billion in 2023, then plunged by 33.55% to $873.1 million in 2024, then slumped by 42.26% to $504.2 million in 2025, then climbed by 21.01% to $610.1 million in 2026.
• The last three Invested Capital figures came in at $610.1 million (Q1 2026), $504.2 million (Q4 2025), and $724.7 million (Q3 2025), per Business Quant data.